Australian company Dimerix (ASX:DXB) has received an initial payment of €6.5 million ($10.7 million) from its partner, UK-based Advanz Pharma.
Dimerix receives first payment from UK-based partner for DMX-200
November 6, 2023 Australian Biotech
Latest Video
New Stories
-
‘Game-changer’ clinical trial launches for Australia’s second-deadliest cancer
April 29, 2025 - - Latest News -
These system-shifting therapies come along every few years, but this is different
April 29, 2025 - - Latest News -
Culture review delivers a scathing assessment of New Zealand's Pharmac
April 29, 2025 - - Latest News -
Pfizer-commissioned survey reveals rising GP concerns over medical misinformation
April 29, 2025 - - Latest News -
New survey confirms significant interest in accessing weight loss therapies
April 28, 2025 - - Latest News -
Medicines Australia announces appointment of communications director
April 28, 2025 - - Latest News -
Recce Pharmaceuticals enters research and development agreement with US defence
April 28, 2025 - - Australian Biotech